Xenon Pharmaceuticals
Matthew Ronsheim serves as the Chief Operating Officer at Xenon Pharmaceuticals Inc. Previously, Matthew held the position of Director of Project Leadership and Global Pharmaceutical Commercialization at Merck. With a strong background in pharmaceutical operations and commercialization, Matthew Ronsheim brings valuable expertise to the biotechnology sector.
This person is not in any teams
This person is not in any offices
Xenon Pharmaceuticals
1 followers
Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders.